scispace - formally typeset
Open AccessJournal ArticleDOI

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

Reads0
Chats0
TLDR
It is demonstrated that miRNAs are present in the serum and plasma of humans and other animals such as mice, rats, bovine fetuses, calves, and horses, and can serve as potential biomarkers for the detection of various cancers and other diseases.
Abstract
Dysregulated expression of microRNAs (miRNAs) in various tissues has been associated with a variety of diseases, including cancers. Here we demonstrate that miRNAs are present in the serum and plasma of humans and other animals such as mice, rats, bovine fetuses, calves, and horses. The levels of miRNAs in serum are stable, reproducible, and consistent among individuals of the same species. Employing Solexa, we sequenced all serum miRNAs of healthy Chinese subjects and found over 100 and 91 serum miRNAs in male and female subjects, respectively. We also identified specific expression patterns of serum miRNAs for lung cancer, colorectal cancer, and diabetes, providing evidence that serum miRNAs contain fingerprints for various diseases. Two non-small cell lung cancer-specific serum miRNAs obtained by Solexa were further validated in an independent trial of 75 healthy donors and 152 cancer patients, using quantitative reverse transcription polymerase chain reaction assays. Through these analyses, we conclude that serum miRNAs can serve as potential biomarkers for the detection of various cancers and other diseases.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Activated platelets can deliver mRNA regulatory Ago2•microRNA complexes to endothelial cells via microparticles

TL;DR: It is demonstrated that human platelets activated with thrombin preferentially release their miR-223 content in MPs, which support a scenario by which platelet MPs may act as intercellular carriers of functional Ago2•microRNA complexes that may exert heterotypic regulation of gene expression in endothelial cells, and possibly other recipient cells of the circulatory system.
Journal ArticleDOI

Deregulation of microRNA-503 Contributes to Diabetes Mellitus–Induced Impairment of Endothelial Function and Reparative Angiogenesis After Limb Ischemia

TL;DR: The discovery that microRNA-503 expression in ECs is upregulated in culture conditions mimicking diabetes mellitus and ischemia-associated starvation and evidence that miR-503expression is increased in ischemic limb muscles of streptozotocin-diabetic mice and inECs enriched from these muscles are suggested.
Journal ArticleDOI

Noncoding RNAs, cytokines, and inflammation-related diseases

TL;DR: Findings in the field are summarized, highlighting those noncoding RNAs that regulate inflammation, with emphasis on recognized mediators such as TNF‐α, IL‐1,IL‐6, IL-18, intercellular adhesion molecule 1, VCAM‐1 and plasminogen activator inhibitor 1.
Journal ArticleDOI

Expression Profile of MicroRNAs in Young Stroke Patients

TL;DR: It is demonstrated that the peripheral blood miRNAs and their profiles can be developed as biomarkers in diagnosis and prognosis of cerebral ischaemic stroke.
References
More filters
Journal Article

MicroRNA signatures in human cancers

TL;DR: The causes of the widespread differential expression of miRNA genes in malignant compared with normal cells can be explained by the location of these genes in cancer-associated genomic regions, by epigenetic mechanisms and by alterations in the miRNA processing machinery as discussed by the authors.
Journal Article

Oncomirs : microRNAs with a role in cancer

TL;DR: I MicroRNAs (miRNAs) are an abundant class of small non-protein-coding RNAs that function as negative gene regulators as discussed by the authors, and have been shown to repress the expression of important cancer-related genes and might prove useful in the diagnosis and treatment of cancer.
Journal ArticleDOI

Real-time quantification of microRNAs by stem–loop RT–PCR

TL;DR: A novel microRNA quantification method has been developed using stem–loop RT followed by TaqMan PCR analysis, which enables fast, accurate and sensitive miRNA expression profiling and can identify and monitor potential biomarkers specific to tissues or diseases.
Related Papers (5)